Menu
Back to User profile » Dr Michael Humphries
Papers published by Dr Michael Humphries:
Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study
Wedzicha JA, Zhong N, Ichinose M, Humphries M, Fogel R, Thach C, Patalano F, Banerji D
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:339-349
Published Date: 19 January 2017
Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis
Vogelmeier C, Zhong NS, Humphries MJ, Mezzi K, Fogel R, Bader G, Patalano F, Banerji D
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:3189-3197
Published Date: 14 December 2016
Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study [Corrigendum]
Wang C, Sun T, Huang Y, Humphries M, Bai L, Li L, Wang Q, Kho P, Firth R, D’Andrea P
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1513-1514
Published Date: 30 July 2015
LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD
Zhong N, Wang C, Zhou X, Zhang N, Humphries M, Wang L, Thach C, Patalano F, Banerji D
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1015-1026
Published Date: 5 June 2015
Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study
Wang C, Sun T, Huang Y, Humphries M, Bai L, Li L, Wang Q, Kho P, Firth R, D’Andrea P
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:57-68
Published Date: 5 January 2015